Rhuzdah - Contraception | Aurobindo Pharma Limited | Dama Drug Checker

Rhuzdah

by Aurobindo Pharma LimitedContraceptionCOCP

DiscontinuedGeneric

Estrogen

Ethinyl Estradiol

0.035Mg

Progestin

Norethindrone

0.4Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

Moderate

Approval Date

10/11/2022

Additives

None

Inactive Ingredients

anhydrous lactoselactose monohydratecolloidal silicon dioxidedibasic calcium phosphate dihydrateFD&C Yellow #6 Aluminum Lakemagnesium stearatepovidonesodium starch glycolate (potato)talccroscarmellose sodiumFD&C Blue No. 2 Aluminum Lakeferric oxide yellowmicrocrystalline cellulose

Contains common allergens

Active Alternative Brands

Alternative brands with the same formulation that are actively prescribed

Aurobindo Pharma Limited(same manufacturer)

Barr Laboratories Inc

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Glenmark Pharmaceuticals Inc., USA

Endo Operations Ltd

Watson Laboratories Inc

Norethindrone And Ethinyl Estradiol

Amneal Pharmaceuticals Of New York Llc

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Lupin Ltd

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Naari Pte Ltd

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Xiromed Llc

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Northstar Rx LLC

Lupin Pharmaceuticals, Inc.

Amneal Pharmaceuticals NY LLC

Teva Pharmaceuticals Usa Inc.

Have clinical questions about Rhuzdah?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy